Immuron Ltd — Regulatory Filings 2004

May 18, 2004

May 19th 2004

Company Announcement Office Australian Stock Exchange Ltd (ASX) 4^th Floor, 20 Bridge Street Sydney NSW 2000

Dear Sir/Madam

Please find herewith a company announcement "First Export To China" for release and distribution to the market immediately.

On Behalf Of ANADIS LIMITED

CONOR GRAHAM Managing Director & CEO

First Export To China

Anadis is pleased to announce that a first shipment of colostrum based product has been recently shipped to China, as a further expansion of Anadis' "Nutraceuticals to Asia" drive. Anadis' Colostrum is beginning to be accepted as the premium Colostrum product, with a significantly higher percentage of IgG (Immunoglobulin G) and protein levels than competing products. This high quality has been made possible through the use of patented collection technologies co-jointly developed by Anadis and Tatura Milk Industries.

This shipment to the Guangzhou region represents the first of an anticipated series of colostrum product orders into this southern region of China and is the culmination of over eighteen months of negotiations. In addition to the Guangzhou region. Anadis is actively pursuing further opportunities with other companies based in the Shanghai, Nanjing and Shenzen regions of China. Anadis expects other orders will follow shortly due to the high demand for quality Colostrum and other, dairy based health products in this rapidly growing market.

For more information please contact Steven Skorobogaty - General Manager Email: stevens@anadis.com.au $\alpha$ r Arie Nudel - Investor Relations Email: arie.n@anadis.com.au

Tel: +61 3 9358 6388 Fax: +61 3 9358 6399